A predictive risk‐scoring model for survival prognosis of multiple myeloma based on gain/amplification of 1q21: Experience in a tertiary hospital in South‐Western China
Abstract Background Chromosomal 1q gains and amplifications (+1q21) are frequently observed in patients with newly diagnosed multiple myeloma (NDMM). However, the interpretation of the high‐risk (HR) prognostic implications stemming from 1q21 abnormalities remain challenging to implement effectively...
Saved in:
| Main Authors: | Yanqiu Xiong, Shanshan Liang, Wenjiao Tang, Li Zhang, Yuhuan Zheng, Ling Pan, Ting Niu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-09-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.70193 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ARNT/HIF‐1β links high‐risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma
by: Chuan Wu, et al.
Published: (2018-08-01) -
Significance of the peripheral blood Treg/Th17 ratio as a prognostic immune biomarker in newly diagnosed multiple myeloma and its correlation with 1q21 gain/amplification
by: Jingjing Wen, et al.
Published: (2025-05-01) -
Hub genes and associated drugs for multiple myeloma with 1q21+: identified by bioinformatic analysis
by: Zhiqiang Xu, et al.
Published: (2024-12-01) -
A case of pulmonary mucosa-associated lymphoid tissue lymphoma diagnosed by detecting t(11;18)(q21;q21) in bronchial lavage fluid
by: Yusuke Nakamura, et al.
Published: (2024-01-01) -
Acquired duplication of isochromosome 21's resulting in pentasomy 21 with concurrent 13q deletion in acute lymphoblastic leukemia: a rare co-occurrence
by: Suhaib Mohammad Ali Abunaser, et al.
Published: (2024-02-01)